StockData
VSee Health, Inc. logo

VSee Health, Inc. (VSEEW) stock

VSEEWOTCServices-Health ServicesFiscal year ends December 31Also trades as VSEE, VSEED
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.02+0.00 (+8.23%)

Close on Oct 9, 2026Market cap $965.84KP/E –Yield –

VSee Health, Inc. grew revenue 10.1% to $12.63M over the twelve months to Jun 30, 2026. Free cash flow was -$6.44M. At the latest close the market valued the company at $965.84K.

Revenue
$12.63M
+10.1% vs. a year earlier
Operating income
-$11.17M
TTM Q2 2026
Free cash flow
-$6.44M
TTM Q2 2026
EPS, diluted
-$0.35
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$965.84K
P/E ratio
–
Price to sales
0.08
Price to book
–
Dividend yield
–
Free cash flow yield
-666.41%

Fundamentals

Revenue
$12.63M
Net income
-$12.48M
EPS, diluted
-$0.35
Free cash flow
-$6.44M
Diluted shares
54M

Trading

Previous close
$0.02
Open
$0.02
Day's range
$0.02 – $0.02
Volume
182,689
Average volume (20 days)
24,369

Market cap history

Month-end market cap since 2024, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 9, 2026. The S&P 500 is measured by the SPY fund.

PeriodVSEEWS&P 500DifferenceVSEEW per yearS&P 500 per year
1 month-4.8%+2.4%−7.1 pts
3 months-40.4%+3.8%−44.2 pts
Year to date-77.5%+15.1%−92.6 pts
1 year-20.4%+17.3%−37.6 pts

Five years at a glance

Fiscal years 2021 to 2025 and trailing twelve months, USD

Revenue

$12.63M+10.1% YoY

Gross profit

$5.31M-30.5% YoY

Operating income

-$11.17M

Net income

-$12.48M

EPS, diluted

-$0.35

Free cash flow

-$6.44M
Reported periodTrailing twelve months

Press releases

Releases VSee Health filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About VSee Health

Services-Health Services

VSee Health, Inc. provides digital healthcare and telehealth technology solutions designed to facilitate patient engagement, clinical coordination, and critical care delivery. Through its subsidiary VSee Lab, the company offers a modular, no-code and low-code telehealth software platform featuring tools for virtual patient visits, appointment scheduling, intake management, remote medical examinations, and remote patient monitoring. Through its subsidiary iDoc, the company delivers specialized tele-intensive care and virtual specialist staffing services, including neurocritical, cardiac, and pulmonary critical care coverage, as well as electronic consultations across numerous medical specialties. Its primary customers include health systems, large and small hospitals, long-term acute care facilities, and the Federal Bureau of Prisons.

Company profile, executives and history

VSee Health stock: common questions

What is VSee Health's stock price?

VSEEW closed at $0.02 on Oct 9, 2026, up 8.23% on the day.

What is VSee Health's market cap?

VSee Health was worth $965.84K at the close on Oct 9, 2026: the share price times the diluted shares outstanding.

What is VSEEW's P/E ratio?

VSee Health lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.35), so it has no meaningful P/E ratio.

How much revenue does VSee Health make?

VSee Health reported revenue of $12.63M for the twelve months to Jun 30, 2026, up 10.1% from a year earlier.

Does VSee Health pay a dividend?

No. VSee Health has not paid a cash dividend over the last twelve months.

How has VSEEW stock performed over the past year?

Including dividends, VSEEW returned -20.4% over the past year, against +17.3% for the S&P 500.

Who are VSee Health's competitors?

Companies most similar to VSee Health by business, industry and size include EUDA, ALPS, MRAI, DCGO, CRVW.